Shorter CAG repeat length in the androgen receptor gene is associated with more aggressive forms of breast cancer
- 1 January 2000
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 59 (2) , 153-161
- https://doi.org/10.1023/a:1006356502820
Abstract
The androgen receptor (AR) is a transcription factor mediating the action of androgens. The AR gene is localized on chromosome X and it contains a series of CAG trinucleotide repeats. The length of the CAG repeats varies among individuals and this polymorphism is believed to be related to AR transcriptional activity. Studies have shown that fewer CAG repeats are associated with an increased risk as well as more aggressive forms of prostate cancer. Although AR is expressed in breast cancer and the impact of androgen and AR on breast cancer has been recognized, the role of the CAG repeats in breast cancer remains unknown. In this study, we measured the CAG repeats in breast cancer tissue using a PCR-based method. Of the 133 patients with primary breast cancer, 102 were heterozygous and 31 were homozygous. The mean CAG repeat number for homozygous women was 21; for heterozygous women the repeat number mean was 20 for the short allele and 24 for the long allele. The length of CAG repeats either in one allele or in both alleles was inversely correlated with the histological grade of breast cancer (r = −0.23 or −0.26, respectively, p<0.05). An association between positive lymph nodes and fewer CAG repeats in both alleles was also suggested (p = 0.06). Furthermore, survival analysis indicated that the total number of CAG repeats in both alleles was associated with patient overall survival. With every CAG repeat increase, there was a 6% reduction in the risk of death (RR = 0.94, p = 0.03). The association remained significant after controlling for the homozygous and heterozygous status (RR = 0.92, p = 0.01). The association became no longer significant when clinical and pathological variables were adjusted in the analysis but this could be due to the reduction of sample size in the multivariate analysis. CAG heterozygosity and difference in number of CAG repeats between the two alleles were not associated with either disease features or patient survival. Our results suggest that longer CAG repeats may occur more frequently in less aggressive cancer and that the CAG repeats may play a role in breast cancer progression.Keywords
This publication has 20 references indexed in Scilit:
- Modification of BRCA1-Associated Breast Cancer Risk by the Polymorphic Androgen-Receptor CAG RepeatAmerican Journal of Human Genetics, 1999
- Circulating concentrations of insulin-like growth factor I and risk of breast cancerThe Lancet, 1998
- Prostate specific antigen in breast cancer, benign breast disease and normal breast tissueBreast Cancer Research and Treatment, 1996
- Serum Sex Hormone Levels After Menopause and Subsequent Breast CancerJNCI Journal of the National Cancer Institute, 1996
- The Androgen Receptor in Prostate CancerPathology - Research and Practice, 1996
- Androgens induce divergent proliferative responses in human breast cancer cell linesThe Journal of Steroid Biochemistry and Molecular Biology, 1995
- Transcriptional Activation Modulated by Homopolymeric Glutamine and Proline StretchesScience, 1994
- Immunohistochemical determination of androgen receptors in relation to oestrogen and progesterone receptors in female breast cancerInternational Journal of Cancer, 1992
- Endocrine therapy for advanced breast cancer: A reviewBreast Cancer Research and Treatment, 1992
- Androgen receptor expression in human tissues: an immunohistochemical study.Journal of Histochemistry & Cytochemistry, 1991